Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −2 vs. Q4 2021
- Shares held
- 4.16M
- −237.2K (−5.4%) vs. Q4 2021
- Total value
- $14.0M
- −$3.61M (−20.5%) vs. Q4 2021
- New holders
- 5
- 10 more added
- Sold out
- 7
- 9 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,421,099 | $4.78M | 0.00% | −9,473−0.7% | Reduced |
| BlackRock Inc. | 474,510 | $1.59M | 0.00% | +2,034+0.4% | Added |
| Ikarian Capital, LLC | 304,161 | $1.02M | 0.31% | +14,611+5.0% | Added |
| Geode Capital Management, LLC | 283,485 | $952.0K | 0.00% | +5,384+1.9% | Added |
| Abner Herrman & Brock LLC | 265,000 | $890.0K | 0.12% | +32,000+13.7% | Added |
| JPMorgan Chase & Co | 246,202 | $827.0K | 0.00% | +53,036+27.5% | Added |
| Raymond James & Associates | 190,403 | $640.0K | 0.00% | +900+0.5% | Added |
| Millennium Management LLC | 141,253 | $475.0K | 0.00% | −8,913−5.9% | Reduced |
| Weaver Consulting Group | 130,000 | $437.0K | 0.21% | −25,500−16.4% | Reduced |
| State Street Corp | 96,060 | $323.0K | 0.00% | +9,357+10.8% | Added |
| Susquehanna International Group, LLP | 94,600 | $318.0K | 0.00% | +94,600 | New |
| Price T Rowe Associates Inc | 93,000 | $312.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 55,916 | $188.0K | 0.00% | −3,175−5.4% | Reduced |
| Group One Trading, L.P. | 49,097 | $165.0K | 0.00% | +49,097 | New |
| Morgan Stanley | 49,106 | $164.0K | 0.00% | −2,554−4.9% | Reduced |
| Jmac Enterprises LLC | 45,430 | $153.0K | 0.04% | +45,430 | New |
| IFP Advisors, Inc | 19,850 | $104.0K | 0.00% | +19,850 | New |
| Boothbay Fund Management, LLC | 29,186 | $98.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 24,119 | $81.0K | 0.00% | +24,119 | New |
| Wells Fargo & Company | 16,225 | $55.0K | 0.00% | −2,333−12.6% | Reduced |
| S.C. Financial Services, Inc. | 15,285 | $51.0K | 0.07% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 12,500 | $42.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,250 | $41.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 12,031 | $40.0K | 0.00% | 00.0% | Unchanged |
| CFO4Life Group, LLC | 12,000 | $40.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,287 | $38.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 11,000 | $37.0K | 0.00% | −600−5.2% | Reduced |
| UBS Group AG | 7,706 | $26.0K | 0.00% | −6,701−46.5% | Reduced |
| Steward Partners Investment Advisory, LLC | 7,700 | $26.0K | 0.00% | −2,000−20.6% | Reduced |
| Bank of America Corp | 7,222 | $24.0K | 0.00% | +4,130+133.6% | Added |
| Institutional & Family Asset Management, LLC | 3,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $8.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,378 | $7.00K | 0.00% | +2,178+1,089.0% | Added |
| Royal Bank of Canada | 1,533 | $5.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $1.62K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10,839 | – | – | +719+7.1% | Added |
| Sabby Management, LLC | 0 | $0 | 0.00% | −513,211−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −4,167−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,442−100.0% | Sold out |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |